半月軟骨修復市場規模、佔有率和趨勢分析 |全球| 2026–2032 | 包括植入、縫線及其他1項

2025年，全球半月軟骨修復市場規模超過6億美元。預計該市場將以3.5%的複合年成長率成長，到2032年達到近8億美元。

本報告涵蓋半月軟骨修復手術中使用的植入、縫線和混合器械。報告根據截至2022年的歷史數據和截至2032年的預測數據，對各公司的銷售量、手術例數、平均售價、市場規模、成長率和市場佔有率進行了定量分析。

該市場受半月軟骨撕裂持續高發以及用於確定手術指徵的特定醫學標準的影響。長期治療效果與患者選擇的準確性和手術技巧密切相關，而由於半月軟骨組織自我療癒能力的局限性，受損半月軟骨組織的完全再生仍然是一項重大的臨床挑戰。生物誘導增強方法正被擴大用於在半月軟骨無血管區域誘導更強的生物反應。

半月軟骨切除術から組織温存術への明確な移行が、市場の成長軌道を決定づけています。「半月軟骨を温存する（Save the Meniscus）」という理念が、オールインサイド修復システム、生体スキャフォールド、およびノットレス固定技術における急速な製品開発を牽引しており、現在、オールインサイド術式は世界の年間半月軟骨手術の60％以上を占めています。

市場概覽

全球半月軟骨修復市場是整形外科運動醫學領域一個界限分明的細分市場，其形成主要基於活躍人群和老年人群中半月軟骨斷裂的穩定發病率。該市場受多種因素共同影響，包括損傷發生率、嚴格的患者篩選標準以及在自身再生能力有限的組織中實現持久修復所需的技術複雜性。並非所有半月軟骨都符合成功修復所需的解剖和血管標準，而長期治療效果與精準的患者篩選和修復技術的精確性密切相關。

「拯救半月軟骨」運動已確立組織保留作為切除術的臨床指南。在關鍵市場，創傷性斷裂修復的數量開始超過組織切除術，推動了全縫合系統、全內視鏡輸送裝置以及旨在促進無血管區域癒合的生物支架等技術的快速創新。隨著這一轉變的推進，製造商競相擴大其產品可修復的斷裂類型和患者群體範圍，因此這三種產品類型的競爭也日益激烈。

オールインサイド修復システムは、世界的に主流の手術形式として台頭してきました。これらのシステムは、組織への損傷を最小限に抑えること、後角などの狭い関節腔へのアクセスを容易にすること、そして外来手術センターの運営上の要求に沿った手術効率を優先しています。インサイドアウト縫合法は、植入のアクセスが制限される複雑な内側半月軟骨斷裂において依然として有用ですが、オールインサイド植入の到達範囲、固定強度、および挿入精度が向上するにつれて、その適用はますます専門化が進んでいます。現在、オールインサイド,システムは、世界の年間半月軟骨手術の60％以上を占めています。

生物誘導增強技術是市場上一個新興的成長領域。旨在刺激無血管區域生物癒合的植入，直接解決了半月軟骨修復的根本挑戰之一：由於血管供應有限，自然修復反應無法發生。隨著這些技術的臨床證據不斷增加，以及與全內固定和混合平台的整合不斷深入，生物誘導方法有望擴大外科醫生認為可修復的斷裂範圍，而不再局限於部分組織切除。

市場促進因素

半月軟骨保存

「拯救半月板」運動已確立組織保留作為首選的手術理念，使治療重心從半月軟骨轉向半月板修復，並應用於越來越多的斷裂板撕裂病例。儘管修復和切除在短期功能結果方面仍存在一些差異，但越來越多的長期證據支持保留半月板是預防關節退化的更優策略。在主要市場，創傷性斷裂的修復手術數量已開始超過切除手術的數量。在此背景下，旨在促進無血管區域（自然修復能力最有限）癒合的全縫合系統和生物支架的研發正在加速推進。隨著修復範圍的擴大和臨床對保守治療效果信心的增強，預計這一趨勢將在整個預測期內持續商業性市場成長。

技術進步和產品演進

生物材料、細胞技術和3D列印技術的顯著進步正在拓展可治療的斷裂類型範圍，並改善複雜病例的治療效果。 2025年3月的一項重要進展是開發出3D列印的可客製化水凝膠，該水凝膠透過匹配患者組織的硬度和生化特性來治療局部斷裂。這標誌著向更個性化、更俱生物活性的修復方案邁出了重要一步。史密斯-內普公司（Smith & Nephew）的STITCH試驗的長期臨床數據證實了修復複雜撕裂類型（例如水平撕裂）的可行性，NOVOSTITCH Pro在五年的隨訪中展現出較高的癒合率和更佳的患者報告結果。全內固定手術、無結輸送系統和低輪廓植入設計的持續改進有望保持植入修復的優勢，同時逐步擴大組織保留而非切除的臨床適應症。

市場限制

禁忌症和患者選擇

由於半月軟骨斷裂的發生率相對穩定，且手術適應症有嚴格的禁忌症，因此半月軟骨修復市場自然受到限制。根據斷裂的類型和位置、組織的血管分佈以及相關的膝關節病變進行仔細的患者篩選，仍然是決定手術成功和復原效果的最重要因素。由於組織自身修復能力有限，受損半月軟骨組織的完全再生難以實現，尤其是在無血管區域。雖然像 REGENETEN 生物誘導植入植入這樣的生物誘導植入物可以透過刺激更強的生物反應來幫助克服這些修復限制，但它們並不能完全消除組織生物學特性固有的禁忌症，因此與半月軟骨的普遍發病率相比，能夠接受手術治療的患者數量有限。

縫合手術時間增加

內外半月軟骨修復術可靈活治療各種類型的斷裂，但與全內植入系統相比，其手術時間較長，限制了其應用。混合式和全內植入系統的速度優勢使得這些技術每年在全球半月軟骨手術中佔比超過60%，縫合修復術則成為一種特殊情況，僅限於無法植入方法的病例。日間手術中心（ASC）膝關節手術量的增加進一步推動了這一趨勢，因為這些機構為了維持盈利，優先考慮縮短麻醉時間、簡化器械包和提高手術室週轉率。與速度更快的全內植入和混合式方法相比，手術時間的結構性限制限制了縫合修復術的發展潛力。

目錄

調查方法

• 第一步：專案推出與團隊組建
• 步驟二：資料系統開發與二次調查實施
• 步驟三：準備面試設計問卷
• 第四步：進行初步調查
• 第五步：調查分析：基準估計
• 第六步：市場預測與分析
• 第七步：辨識策略機遇
• 步驟 8：最終確認和市場公告
• 步驟九：客戶回饋與市場監測

全球關稅的影響

半月軟骨修復市場

• 執行摘要
  • 全球半月軟骨修復市場概覽
  • 競爭分析
  • 目標市場
  • 目標區域
• 介紹
• 治療次數
• 市場概覽
  • 按細分市場
  • 按地區
• 市場分析與預測
  • 半月軟骨修復市場整體狀況
  • 半月軟骨修復市場
• 促進因素和抑制因素
  • 市場促進因素
  • 市場限制因素
• 競爭性市佔率分析

簡稱

The global meniscal repair market was valued at over $600 million in 2025. The market is expected to grow at a compound annual growth rate (CAGR) of 3.5%, reaching just under $800 million by 2032.

This report covers implants, sutures, and hybrid devices used in meniscal repair procedures. It quantifies unit sales, procedure numbers, average selling prices (ASPs), market values, growth rates, and company shares, with historical data back to 2022 and forecasts through 2032.

The market is shaped by a steady frequency of meniscal injuries and the specific medical criteria that determine surgical candidacy. Long-term success is closely tied to patient selection accuracy and surgical technique, and complete regeneration of damaged meniscal tissue remains a significant clinical challenge due to the tissue's limited natural healing capacity. Bioinductive augmentation approaches are increasingly being used to stimulate a more robust biological response in the avascular zones of the meniscus.

A clear shift from meniscectomy toward tissue preservation is defining the market's growth trajectory. The Save the Meniscus philosophy is driving rapid product development in all-inside repair systems, biological scaffolds, and knotless fixation technologies, with all-inside techniques now accounting for over 60% of annual global meniscal surgeries.

Market Overview

The global meniscal repair market is a well-defined segment within orthopedic sports medicine, supported by a steady incidence of meniscal tears across active and aging populations. The market is shaped by the intersection of injury frequency, strict patient selection criteria, and the technical complexity of achieving durable repair in tissue with limited natural regenerative capacity. Not all meniscal tears meet the anatomical and vascular criteria required for successful repair, and long-term outcomes are closely tied to accurate patient selection and the precision of the repair technique.

The Save the Meniscus movement has firmly established tissue preservation as the preferred clinical philosophy over meniscectomy. In leading markets, repair volumes for traumatic tears have begun to surpass tissue removal procedures, driving rapid innovation in all-suture systems, all-inside delivery devices, and biological scaffolds designed to enhance healing in avascular zones. This shift is intensifying competition across all three product categories as manufacturers work to expand the range of tear types and patient profiles eligible for repair.

All-inside repair systems have emerged as the dominant surgical format globally. These systems prioritize minimal tissue disruption, easier access to tight joint spaces such as the posterior horn, and procedural efficiency that aligns with the operational demands of ambulatory surgery centers. Inside-out suture techniques remain relevant for complex medial tears where implant access is limited, but they have become increasingly specialized as all-inside implants improve in reach, fixation strength, and delivery precision. All-inside systems now account for over 60% of annual global meniscal surgeries.

Bioinductive augmentation is an emerging growth area within the market. Implants designed to stimulate biological healing in avascular zones directly address one of the fundamental limitations of meniscal repair, where restricted vascularity limits the natural repair response. As clinical evidence for these technologies grows and integration with all-inside and hybrid platforms improves, bioinductive approaches are expected to expand the pool of tears that surgeons consider repairable rather than amenable only to partial tissue removal.

Market Drivers

Meniscal Preservation

The Save the Meniscus movement has solidified tissue preservation as the preferred surgical philosophy, shifting the balance from meniscectomy toward repair for an expanding range of tear types. While some variation in short-term functional outcomes between repair and removal persists, long-term evidence increasingly supports preservation as the superior strategy for preventing joint degeneration. In leading markets, repair volumes for traumatic tears have now begun to surpass removal procedures. This shift is driving rapid product development in all-suture systems and biological scaffolds designed to enhance healing in avascular zones where natural repair capacity is most limited. As repair indications expand and clinical confidence in preservation outcomes strengthens, this movement is expected to remain the primary commercial driver for the market through the forecast period.

Improved Technologies and Product Advancements

Significant advances in biomaterials, cell-based technologies, and 3D printing are expanding the range of treatable tear patterns and improving outcomes for complex cases. A notable development in March 2025 involved a 3D-printed customizable hydrogel designed to treat localized tears by matching the stiffness and biochemical properties of the patient's native tissue, representing a step toward more personalized and biologically active repair solutions. Long-term clinical data from Smith and Nephew's STITCH study has reinforced the viability of repairing complex tear types such as horizontal cleavage tears, with the NOVOSTITCH Pro demonstrating high healing rates and improved patient-reported outcomes at five-year follow-up. The continued refinement of all-inside techniques, knotless delivery systems, and low-profile implant designs is expected to sustain the dominance of implant-based repair while gradually extending the clinical indications for preservation over removal.

Market Limiters

Contraindications and Patient Selection

The meniscal repair market is naturally limited by the relatively stable incidence rate of meniscal tears and the strict contraindications that govern surgical candidacy. Careful patient selection based on tear type, location, tissue vascularity, and associated knee pathology remains the most critical determinant of surgical success and rehabilitation outcome. Complete regeneration of damaged meniscal tissue is difficult to achieve due to the tissue's inherently limited healing capacity, particularly in avascular zones. While bioinductive implants such as the REGENETEN Bioinductive Implant are helping to address these healing limitations by stimulating a stronger biological response, they do not fully eliminate the contraindications built into the tissue's biology, keeping the addressable procedure population constrained relative to the broader prevalence of meniscal pathology.

Increased Operation Time for Suture Techniques

Inside-out suture meniscal repair offers versatility across tear types but requires longer operative times compared to all-inside implant systems, limiting its growth relative to faster alternatives. The procedural speed advantage of hybrid and all-inside implant systems has driven these formats to account for over 60% of global meniscal surgeries annually, reducing suture repair to a specialized niche for cases where implant-based access is not feasible. The growing prevalence of ASC-based knee procedures reinforces this dynamic, as these facilities prioritize shorter anesthesia times, streamlined instrument sets, and efficient room turnover to maintain profitability. Structural pressure on operative time constrains the suture segment's growth potential relative to faster all-inside and hybrid alternatives.

Market Coverage and Data Scope

• Quantitative coverage: Procedure numbers, market size, market shares, market forecasts, growth rates, units sold, and average selling prices.
• Qualitative coverage: Growth trends, market limiters, competitive analysis and SWOT for top competitors, mergers and acquisitions, company profiles and product portfolios, and practice trends shaping demand.
• Time frame: Base year 2025, forecasts 2026 to 2032, historical data 2022 to 2024.
• Data sources: Primary interviews with orthopedic industry leaders and sports medicine surgeons, regulatory data, hospital and ASC procurement data, import and export data, and the iData Research internal database.
• Care settings: Hospitals, ambulatory surgery centers, and orthopedic specialty clinics.

Markets Covered and Segmentation

• The meniscal repair market is analyzed across three product categories, each assessed by unit volume, ASP, and market value with historical and forecast data:
• Meniscal Repair Implants Market
• Meniscal Repair Sutures Market
• Meniscal Repair Hybrid Market

Competitive Analysis

Smith and Nephew holds the leading share of the total meniscal repair market, representing more than one-third of the global sector in 2025. This leadership is rooted in early innovation in the all-inside repair category beginning with the FasT-Fix system, which has been consistently strengthened with the FasT-Fix 360, Ultra-Fast-Fix, and the NovoStitch Pro system for complex tear patterns including radial and horizontal cleavage tears. The Fast-Fix Flex is a flagship offering and the only all-inside system featuring a surgeon-guided bendable needle and shaft, enabling access to all zones of the meniscus including the posterior horn and mid-body while minimizing chondral damage risk. Long-term data from the STITCH study has further reinforced the clinical evidence supporting these platforms.

Arthrex remains the second leading competitor in the meniscal repair market in 2025. The company's all-inside portfolio is led by the FiberStitch 1.5 implant, which uses soft all-suture sheaths and a low-profile 1.5 mm needle to minimize tissue trauma and morbidity. The Meniscal Cinch II linear delivery system provides high-strength knotless fixation using 2-0 FiberWire. For complex cases, the Knee Scorpion suture passer supports suture passage in tight joint spaces, and the ZoneNavigator system serves inside-out procedures using 0.9 mm SutureTape. A significant 2025 addition is the SutureLoc implant, a knotless all-suture solution for reproducible meniscal root repair without requiring a posterior medial portal.

CONMED maintains a strong position in the market through its expanding joint preservation portfolio. The Infinity AIM Meniscal Repair Device features a hidden implant design that minimizes piercing diameter during deployment. The Sequent Meniscal Repair Device offers PEEK implants and Hi-Fi suture for up to six continuous stitches in a knotless configuration. For inside-out techniques, the Zone Specific II system targets anterior, middle, and posterior zone tears, while the BioBrace reinforced bioinductive implant is increasingly used to augment these repairs.

Technology and Practice Trends

• All-inside system dominance: All-inside implant systems now account for over 60% of annual global meniscal surgeries, favored for minimal tissue disruption, procedural speed, and compatibility with ASC workflows.
• Meniscal preservation philosophy: The Save the Meniscus movement continues to expand repair indications and drive product investment, with repair volumes surpassing meniscectomy in leading markets for traumatic tear types.
• Bioinductive augmentation: Implants designed to stimulate biological healing in avascular zones are growing in adoption and extending the range of tears suitable for preservation-focused management.
• Knotless fixation: Knotless all-inside systems are gaining ground by reducing deployment complexity and improving reproducibility, particularly for posterior horn and root access scenarios.
• 3D printing and biomaterial innovation: Customizable hydrogel scaffolds and patient-specific repair constructs represent an advancing area of product development aimed at matching individual tissue mechanical properties.
• Meniscal root repair: Purpose-built knotless systems for meniscal root attachment are broadening the surgical toolkit for cases where root integrity is central to joint preservation goals.

Geography

This report provides global coverage across North America, Europe, Asia-Pacific, Latin America, the Middle East, and Africa.

Why This Report

• Where are the largest and fastest-growing opportunities within the global meniscal repair market through 2032?
• How is the Save the Meniscus preservation philosophy expanding repair indications and reshaping competitive dynamics across implant, suture, and hybrid categories?
• What role are bioinductive augmentation technologies playing in addressing avascular zone healing limitations and extending the range of repairable tears?
• How are all-inside system improvements and knotless fixation designs affecting market share distribution across the three product categories?
• What is the impact of ASC migration and operative efficiency requirements on suture-based repair growth and product selection across facilities?
• Which companies lead the market and what are their core platforms, recent clinical evidence investments, and product development priorities?
• How do patient selection criteria and biological contraindications shape the total addressable procedure volume in this market?
• What are the key risks to growth, including stable injury incidence, repair contraindications, and the continued competitive pressure from meniscectomy in specific patient profiles?

The Global Meniscal Repair Market Report from iData Research answers these questions with procedure-aware models, company share analysis, and pricing detail. Use it to quantify demand, benchmark competitors, prioritize product development investments, and plan for growth across all major global regions.

TABLE OF CONTENT

Research Methodology

• Step 1: Project Initiation & Team Selection
• Step 2: Prepare Data Systems And Perform Secondary Research
• Step 3: Preparation For Interviews & Questionnaire Design
• Step 4: Performing Primary Research
• Step 5: Research Analysis: Establishing Baseline Estimates
• Step 6: Market Forecast And Analysis
• Step 7: Identify Strategic Opportunities
• Step 8: Final Review And Market Release
• Step 9: Customer Feedback And Market Monitoring

Impact Of Global Tariffs

Meniscal Repair Market

• 9.1 Executive Summary
  • 9.1.1 Global Meniscal Repair Market Overview
  • 9.1.2 Competitive Analysis
  • 9.1.3 Markets Included
  • 9.1.4 Regions Included
• 9.2 Introduction
• 9.3 Procedure Numbers
• 9.4 Market Overview
  • 9.4.1 By Segment
  • 9.4.2 By Region
• 9.5 Market Analysis And Forecast
  • 9.5.1 Total Meniscal Repair Market
  • 9.5.2 Meniscal Repair Market
    • 9.5.2.1 Implant Meniscal Repair Market
    • 9.5.2.2 Suture Meniscal Repair Market
    • 9.5.2.3 Hybrid Meniscal Repair Market
• 9.6 Drivers And Limiters
  • 9.6.1 Market Drivers
  • 9.6.2 Market Limiters
• 9.7 Competitive Market Share Analysis

Abbreviations

LIST OF CHARTS

• Chart 9-1: Meniscal Repair Market, Global, 2025 & 2032
• Chart 9-2: Meniscal Repair Procedures, Global, 2025
• Chart 9-3: Meniscal Repair Procedures by Region, Global, 2022 - 2032
• Chart 9-4: Meniscal Repair Market by Segment, Global, 2022 - 2032
• Chart 9-5: Meniscal Repair Market by Region, Global, 2022 - 2032
• Chart 9-6: Leading Competitors, Meniscal Repair Market, Global, 2025

LIST OF FIGURES

• Figure 9-1: Meniscal Repair Markets Covered
• Figure 9-2: Meniscal Repair Regions Covered, Global (1 of 2)
• Figure 9-3: Meniscal Repair Regions Covered, Global (2 of 2)
• Figure 9-4: Meniscal Repair Procedures by Region, Global, 2022 - 2032
• Figure 9-5: Meniscal Repair Market by Segment, Global, 2022 - 2032 (US$M)
• Figure 9-6: Meniscal Repair Market by Region, Global, 2022 - 2032 (US$M)
• Figure 9-7: Meniscal Repair Market, Global, 2022 - 2032
• Figure 9-8: Units Sold by Region, Meniscal Repair Market, Global, 2022 - 2032
• Figure 9-9: Average Selling Price by Region, Meniscal Repair Market, Global, 2022 - 2032 (US$)
• Figure 9-10: Market Value by Region, Meniscal Repair Market, Global, 2022 - 2032 (US$M)
• Figure 9-11: Meniscal Repair Market by Segment, Global, 2022 - 2032 (US$M)
• Figure 9-12: Total Meniscal Repair Market, Global, 2022 - 2032
• Figure 9-13: Implant Meniscal Market, Global, 2022 - 2032
• Figure 9-14: Units Sold by Region, Implant Meniscal Market, Global, 2022 - 2032
• Figure 9-15: Average Selling Price by Region, Implant Meniscal Market, Global, 2022 - 2032 (US$)
• Figure 9-16: Market Value by Region, Implant Meniscal Market, Global, 2022 - 2032 (US$M)
• Figure 9-17: Suture Meniscal Repair Market, Global, 2022 - 2032
• Figure 9-18: Units Sold by Region, Suture Meniscal Repair Market, Global, 2022 - 2032
• Figure 9-19: Average Selling Price by Region, Suture Meniscal Repair Market, Global, 2022 - 2032 (US$)
• Figure 9-20: Market Value by Region, Suture Meniscal Repair Market, Global, 2022 - 2032 (US$M)
• Figure 9-21: Hybrid Meniscal Repair Market, Global, 2022 - 2032
• Figure 9-22: Units Sold by Region, Hybrid Meniscal Repair Market, Global, 2022 - 2032
• Figure 9-23: Average Selling Price by Region, Hybrid Meniscal Repair Market, Global, 2022 - 2032 (US$)
• Figure 9-24: Market Value by Region, Hybrid Meniscal Repair Market, Global, 2022 - 2032 (US$M)
• Figure 9-25: Leading Competitors, Meniscal Repair Market, Global, 2025